Trial Profile
An Extension Study to Evaluate the Long-term Safety and Efficacy of ORADUR-Methylphenidate in Children and Adolescents With ADHD
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Dec 2021
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Orient Pharma
- 14 Mar 2016 New trial record